Detalhe da pesquisa
1.
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.
J Pathol
; 260(3): 289-303, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37186300
2.
RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.
Breast Cancer Res
; 25(1): 74, 2023 06 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349798
3.
Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.
J Biol Chem
; 295(16): 5427-5448, 2020 04 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-32165498
4.
RHAMM Is a Multifunctional Protein That Regulates Cancer Progression.
Int J Mol Sci
; 22(19)2021 Sep 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34638654
5.
A truncated RHAMM protein for discovering novel therapeutic peptides.
Bioorg Med Chem
; 26(18): 5194-5203, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30249497
6.
HIPPO and Hyaluronan: Partners in Tumor Resistance?
Bioessays
; 42(7): e2000090, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32449182
7.
Cellular heterogeneity profiling by hyaluronan probes reveals an invasive but slow-growing breast tumor subset.
Proc Natl Acad Sci U S A
; 111(17): E1731-9, 2014 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24733940
8.
Corrigendum to "A truncated RHAMM protein for discovering novel therapeutic peptides" [Bioorg. Med. Chem. 26 (2018) 5194-5203].
Bioorg Med Chem
; 28(13): 115543, 2020 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32423782
9.
Elevated hyaluronan and hyaluronan-mediated motility receptor are associated with biochemical failure in patients with intermediate-grade prostate tumors.
Cancer
; 120(12): 1800-9, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24668563
10.
Evaluation of protein biomarkers of prostate cancer aggressiveness.
BMC Cancer
; 14: 244, 2014 Apr 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-24708576
11.
Association of Squamous Cell Carcinoma and Hyaluronan: A Scope of the Literature.
Eplasty
; 24: e11, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38476515
12.
A RHAMM mimetic peptide blocks hyaluronan signaling and reduces inflammation and fibrogenesis in excisional skin wounds.
Am J Pathol
; 181(4): 1250-70, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22889846
13.
Imaging of homeostatic, neoplastic, and injured tissues by HA-based probes.
Biomacromolecules
; 13(1): 12-22, 2012 Jan 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-22066590
14.
RHAMM promotes interphase microtubule instability and mitotic spindle integrity through MEK1/ERK1/2 activity.
J Biol Chem
; 285(34): 26461-74, 2010 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-20558733
15.
Rhamm-/- fibroblasts are defective in CD44-mediated ERK1,2 motogenic signaling, leading to defective skin wound repair.
J Cell Biol
; 175(6): 1017-28, 2006 Dec 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-17158951
16.
Function-Blocking RHAMM Peptides Attenuate Fibrosis and Promote Antifibrotic Adipokines in a Bleomycin-Induced Murine Model of Systemic Sclerosis.
J Invest Dermatol
; 141(6): 1482-1492.e4, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33242499
17.
A Hyaluronan-binding Peptide (P15-1) Reduces Inflammatory and Catabolic Events in IL-1ß-treated Human Articular Chondrocytes.
Sci Rep
; 10(1): 1441, 2020 01 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-31996703
18.
Creating a Favorable Microenvironment for Fat Grafting in a Novel Model of Radiation-Induced Mammary Fat Pad Fibrosis.
Plast Reconstr Surg
; 145(1): 116-126, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31881612
19.
Chondroitin sulfate proteoglycan 4 enhanced melanoma motility and growth requires a cysteine in the core protein transmembrane domain.
Melanoma Res
; 29(4): 365-375, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31140988
20.
Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?
Nat Clin Pract Oncol
; 5(5): 280-90, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18349857